OUR SERVICES

EU GMP Certification

EU GMP certification is a mandatory manufacturing standard for drugs and medical devices sold on the market of EU member countries. The European Union (EU) is one of the world's largest and most important international mainstream markets for pharmaceuticals. Since the GMP certification and inspection results of nearly 30 EU member states are mutually recognized, the EU and the United States, Japan, Australia and other countries have gradually begun to recognize each other's GMP certification.

2024

10-25

FDA cGMP Certification

FDA(Food and Drug Administration) is the food and drug regulatory agency authorized by the United States Congress, which is responsible for supervising and regulating food, drugs, medical devices, cosmetics and other products related to public health. The FDA's primary mission is to ensure the safety, effectiveness, and proper labeling of these products when used by the public.

2024

10-25

PIC/S-GMP Certification

PIC/S GMP certification is an internationally recognized pharmaceutical production quality management practice certification, which aims to ensure the consistency of pharmaceutical production and quality control standards in participating countries, thereby promoting international pharmaceutical trade. Obtaining PIC/S GMP certification means that pharmaceutical companies meet international standards in drug production and quality management, thereby increasing the competitiveness of drugs in the international market. Pharmaceutical companies want to sell drugs in the international market, and obtaining PIC/S GMP certification is a key step.

2024

10-25

China GMP Certification

GMP According to Decree No. 79 of 2011 signed by the Minister of Health of the People's Republic of China, the "Good Manufacturing Practice for Drugs (Revised in 2010)" (hereinafter referred to as the new version of GMP) will come into force on March 1, 2011. The new version of GMP and the EU's GMP system construction and requirements are getting closer and closer, CFDA's management characteristics of the pharmaceutical industry has gradually entered a more standardized trend, therefore, it also requires enterprises to improve the overall GMP management level of enterprises through continuous learning of new technology management.

2024

10-25

< 1 > proceed page